The Latest Cardiac and Vascular News
Analysis of open-label extension data demonstrated that bempedoic acid was generally well tolerated and demonstrated sustained efficacy with up to 2.5 years of continuous treatment May 02, 2022 08:00 ET | Source: Esperion Therapeutics, Inc. ANN ARBOR, Mich., May 02, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced the publication of data […]
Study Presented at the International Society for Heart and Lung Transplant 42nd Annual Meeting and Scientific Sessions 2022 Oak Ridge, TN, May 02, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces new data validating the benefits of the Company’s BVA-100 blood test (BVA) in improving […]
SEOUL, South Korea–(BUSINESS WIRE)–NEXEL, a global leader in induced pluripotent stem cell (iPSC) technology, announced today that it has achieved ISO/IEC 17025:2017 quality standard for laboratory testing, the world’s most respected quality management standard, by the Korea Laboratory Accreditation Scheme(KOLAS). KOLAS is a signatory of the International Laboratory Accreditation Cooperation […]
The Financing round was led by growth equity firm Stripes, and marks Hello Heart’s leadership in cardiovascular digital therapeutics and proven ability to close gaps in heart health – the number one cause of death in the U.S. MENLO PARK, Calif.–(BUSINESS WIRE)–Hello Heart, the only digital therapeutic that focuses on […]
On Its Anniversary, the Inventor of Measure-through Motion and Low Perfusion™ Pulse Oximetry Introduces the First Health Watch to Offer Accurate, Continuous Measurements IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) marks its 33rd anniversary today by announcing the limited market release of the W1™ health watch for consumers. The first of its kind, the […]
Five Northwell hospitals on Long Island and NYC distinguished for superior cardiac outcomes NEW HYDE PARK, NY – Two newly released New York State Department of Health (DOH) reports rank five Northwell Health hospitals as among the state’s best for cardiac surgery and percutaneous coronary interventions (PCI), a non-surgical procedure […]
Former Google Health Executive to Expand Cardiovascular Strategy for Ocular Health Technology Company GUILFORD, Conn., April 28, 2022 — Tesseract Health, a health technology company developing a portable, non-invasive platform to detect health conditions through the eyes, proudly announces the appointment of Michael McConnell, MD, MSEE, as Tesseract’s Head of […]
Treatment with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ resulted in patients with persistent atrial fibrillation experiencing an improved quality of life The catheter is part of Abbott’s suite of electrophysiology solutions designed to improve procedures to address cardiac arrythmias ABBOTT PARK, Ill., April 29, 2022 /PRNewswire/ — Abbott (NYSE: ABT) today […]
MARLBOROUGH, Mass., April 28, 2022 – Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the EMBOLD™ Fibered Detachable Coil, which is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. The first procedure using the device was performed this week […]
Company looks to finalize development of its advanced interventional approach for heart failure management CAMPBELL, Calif., April 29, 2022 /PRNewswire/ — Adona Medical, a Shifamed portfolio company, announced today it has secured $37.5M Series B financing, which will be used to complete product development and support further evaluation of the company’s next-generation heart failure […]
